-
ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9
Stoop, T. F., Doppenberg, D., Katz, M. H. G., Tzeng, C-W. D., Wei, A. C., Zureikat, A. H., Groot Koerkamp, B., Besselink, M. G., van Dieren, S., Theijse, R. T., Janssen, Q. P., Nasar, N. & Prakash, L. R., Mar 2024, In: Annals of surgical oncology. 31, 3, p. 1842-1843 2 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study
Doppenberg, D., Stoop, T. F., van Dieren, S., Katz, M. H. G., Janssen, Q. P., Nasar, N., Prakash, L. R., Theijse, R. T., Tzeng, C-W. D., Wei, A. C., Zureikat, A. H., Groot Koerkamp, B. & Besselink, M. G., Mar 2024, In: Annals of surgical oncology. 31, 3, p. 1919-1932 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)
Dutch Pancreatic Cancer Group, 1 Dec 2023, In: BMC Cancer. 23, 1, 70.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications